A detailed history of Levin Capital Strategies, L.P. transactions in Lucid Diagnostics Inc. stock. As of the latest transaction made, Levin Capital Strategies, L.P. holds 66,528 shares of LUCD stock, worth $51,891. This represents 0.01% of its overall portfolio holdings.

Number of Shares
66,528
Holding current value
$51,891
% of portfolio
0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$0.75 - $0.88 $49,896 - $58,544
66,528 New
66,528 $54,000
Q4 2022

Feb 13, 2023

BUY
$1.21 - $2.27 $44,526 - $83,533
36,799 New
36,799 $50,000

Others Institutions Holding LUCD

About Lucid Diagnostics Inc.


  • Ticker LUCD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 38,568,500
  • Market Cap $30.1M
  • Description
  • Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company. The company focuses on patients with gastroesophageal reflux disease, which is also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarc...
More about LUCD
Track This Portfolio

Track Levin Capital Strategies, L.P. Portfolio

Follow Levin Capital Strategies, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Levin Capital Strategies, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Levin Capital Strategies, L.P. with notifications on news.